![Pearls in a shell](/media/hbmpartners/styles/hero_small/public/images/hero-images/hero-portfolio-companies.jpg?h=14832055&itok=DIQpNLis)
IO Biotech
Industry
Oncology
Website
HBM contact
Company status
Public
Description - IO Biotech is a clinical stage biotech company developing disruptive immune therapies for the treatment of cancer. Our pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules.
![Logo IO Biotech](/media/hbmpartners/images/portfolio/logo/io-biotech_0.jpg)